ESG Viewpoint: Emerging responsible investment trends in Asia

The appetite for responsible investing is growing in Asia, as regulations evolve and client demand increases.

Diversität in klinischen Studien – unser aktiver Dialog mit Pharmaunternehmen  

Lab workers running tests

Um die Qualität und Sicherheit von Arzneimitteln für verschiedene Bevölkerungsgruppen zu testen, ist eine große Vielfalt der Teilnehmer an klinischen Studien von hoher Bedeutung.

CO2-Abscheidung und-Speicherung: Chancen auf einem boomenden Markt

Power plant station next to a nature reserve

CO2-Abscheidung und -Speicherung (CCS) kann einen entscheidenden Beitrag dazu leisten, dass die Welt ihre ehrgeizigen Netto-Null-Emissionsziele erreicht.

ESG Viewpoint: The cost of gender disparity in Asian companies

city centre 1920x500

We’ve been engaging with 26 of Asia’s most influential companies on this topic.

Investment conclusions from 2023’s clean energy sell-off

Offshore windfarms

The clean energy index had a tough 2023, but we believe there was an overreaction in markets that didn’t appreciate the nuance of the energy transition.

ESG Viewpoint: Investing in a Just Transition

Wind Turbine casing opened

It’s essential we consider the social dimension as we transition to a low carbon world. We explore the investment implications of a Just Transition.

Carbon capture and storage: opportunities in a burgeoning market

Power plant station next to a nature reserve

CCS has the potential to play a major role in delivering ambitious emission-reduction targets. We run the rule over the marketplace

ESG Viewpoint: Interpreting climate data for investment portfolios

Wind farm

Climate change and the energy transition will impact the long-term performance of investment portfolios. Here we look at how investors should interpret climate data for managing investment portfolios.

ESG Viewpoint: Diversity in clinical trials  

Lab workers running tests

Despite a clear scientific and commercial imperative, a significant gap between patient and trial populations persists. We explain why diversity in clinical trials matters to investors and explore our engagement with companies.

COP28 – main takeaways and key outcomes

Dubai

A last-minute deal on transitioning away from fossil fuels was agreed – but will commitments be implemented? We assess this and other progress made at the 28th round of climate change negotiations in Dubai.